Studies on aldosterone responsiveness to angiotensin II during clinical variations in calcium metabolism in normal man. 1982

M G Bianchetti, and C Beretta-Piccoli, and P Weidmann, and K Boehringer, and L Link, and J J Morton

1. Angiotensin II was infused at stepwise increasing dose rates (2, 4 and 10 pmol min-1 kg-1) in 12 normal subjects. Infusions were performed in the presence of normocalcaemia, mild hypercalcemia induced by concomitant calcium gluconate infusion, and after 2 weeks of treatment with nifedipine. 2. Pre-infusion plasma levels of angiotensin II, renin or aldosterone were not altered by acute mild hypercalcaemia or administration of nifedipine. The angiotensin II-induced increases in plasma aldosterone were also similar under the three study conditions. 3. Variations in calcium metabolism occurring under clinical conditions appear to play a minor role in modulating the angiotensin II-dependent pathway of aldosterone regulation in normal man.

UI MeSH Term Description Entries
D008297 Male Males
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D012084 Renin-Angiotensin System A BLOOD PRESSURE regulating system of interacting components that include RENIN; ANGIOTENSINOGEN; ANGIOTENSIN CONVERTING ENZYME; ANGIOTENSIN I; ANGIOTENSIN II; and angiotensinase. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming ANGIOTENSIN I. Angiotensin-converting enzyme, contained in the lung, acts on angiotensin I in the plasma converting it to ANGIOTENSIN II, an extremely powerful vasoconstrictor. Angiotensin II causes contraction of the arteriolar and renal VASCULAR SMOOTH MUSCLE, leading to retention of salt and water in the KIDNEY and increased arterial blood pressure. In addition, angiotensin II stimulates the release of ALDOSTERONE from the ADRENAL CORTEX, which in turn also increases salt and water retention in the kidney. Angiotensin-converting enzyme also breaks down BRADYKININ, a powerful vasodilator and component of the KALLIKREIN-KININ SYSTEM. Renin-Angiotensin-Aldosterone System,Renin Angiotensin Aldosterone System,Renin Angiotensin System,System, Renin-Angiotensin,System, Renin-Angiotensin-Aldosterone
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006934 Hypercalcemia Abnormally high level of calcium in the blood. Milk-Alkali Syndrome,Hypercalcemias,Milk Alkali Syndrome,Syndrome, Milk-Alkali
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000450 Aldosterone A hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. Aldosterone, (+-)-Isomer,Aldosterone, (11 beta,17 alpha)-Isomer
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine

Related Publications

M G Bianchetti, and C Beretta-Piccoli, and P Weidmann, and K Boehringer, and L Link, and J J Morton
December 1981, Clinical science (London, England : 1979),
M G Bianchetti, and C Beretta-Piccoli, and P Weidmann, and K Boehringer, and L Link, and J J Morton
January 1989, Clinical and experimental hypertension. Part A, Theory and practice,
M G Bianchetti, and C Beretta-Piccoli, and P Weidmann, and K Boehringer, and L Link, and J J Morton
January 1983, European journal of clinical pharmacology,
M G Bianchetti, and C Beretta-Piccoli, and P Weidmann, and K Boehringer, and L Link, and J J Morton
December 1993, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
M G Bianchetti, and C Beretta-Piccoli, and P Weidmann, and K Boehringer, and L Link, and J J Morton
October 1994, Clinical science (London, England : 1979),
M G Bianchetti, and C Beretta-Piccoli, and P Weidmann, and K Boehringer, and L Link, and J J Morton
October 1983, The Journal of clinical endocrinology and metabolism,
M G Bianchetti, and C Beretta-Piccoli, and P Weidmann, and K Boehringer, and L Link, and J J Morton
June 1968, Klinische Wochenschrift,
M G Bianchetti, and C Beretta-Piccoli, and P Weidmann, and K Boehringer, and L Link, and J J Morton
May 1977, Mayo Clinic proceedings,
M G Bianchetti, and C Beretta-Piccoli, and P Weidmann, and K Boehringer, and L Link, and J J Morton
December 1984, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
M G Bianchetti, and C Beretta-Piccoli, and P Weidmann, and K Boehringer, and L Link, and J J Morton
July 1986, Journal of applied physiology (Bethesda, Md. : 1985),
Copied contents to your clipboard!